Skip to main content
Year archive

GENETIC TECHNOLOGIES LIMITED — 2023 filings

All 63 regulatory filings released by GENETIC TECHNOLOGIES LIMITED (GTG) in 2023, sourced directly from the official regulator.

63 Filings
2023 Period
2023 filings (63)
Filing Released Lang
Notification regarding unquoted securities - GTG 5 pages 26.2KB
Share Issue/Capital Change
2023-12-27 English
Notification of cessation of securities - GTG 4 pages 23.7KB
Regulatory Filings
2023-12-27 English
4xAppendix 3Y-Share Consolidation & Performance Right Expiry 13 pages 610.9KB
Director's Dealing
2023-12-26 English
Receipt of the R & D Tax Incentive Refund 1 page 42
Regulatory Filings
2023-12-17 English
Update - Consolidation/Split - GTG 5 pages 28.3KB
Share Issue/Capital Change
2023-12-06 English
NASDAQ Confirms First Trading Date of Consolidated ADS 2 pages 101.0KB
Share Issue/Capital Change
2023-12-06 English
Update - Consolidation/Split - GTG 5 pages 28.3KB
Share Issue/Capital Change
2023-12-05 English
Updated Share Consolidation Timetable 2 pages 100.7KB
Share Issue/Capital Change
2023-12-05 English
Notification of cessation of securities - GTG 4 pages 23.8KB
Share Issue/Capital Change
2023-12-03 English
Update - Consolidation/Split - GTG 5 pages 28.3KB
Share Issue/Capital Change
2023-11-30 English
Change to Share Consolidation Timetable 2 pages 100.2KB
Share Issue/Capital Change
2023-11-30 English
2023 AGM Presentation 56 pages 4.6MB
AGM Information
2023-11-21 English
Results of 2023 AGM 2 pages 297.3KB
Declaration of Voting Results & Voting Rights Announcements
2023-11-21 English
Consolidation/Split - GTG 5 pages 28.0KB
Share Issue/Capital Change
2023-11-20 English
Proposed Change to Timetable for Resolution 5 2 pages 96.6KB
Regulatory Filings
2023-11-20 English
Appendix 4C and Quarterly Activities Report - September 2023 9 pages 353.1KB
Interim / Quarterly Report
2023-10-29 English
Notice of Annual General Meeting and Proxy Form 28 pages 579.0KB
AGM Information
2023-10-19 English
Date of AGM and Closing Date for Director Nominations 1
AGM Information
2023-09-28 English
GTG & Gold Coast Hospital Announce Precision Medicine Pilot 2 pages 135.7KB
Regulatory Filings
2023-09-27 English
geneType Granted Approval for 3 New Diseases in Australia 2 pages 142.0KB
Regulatory Filings
2023-09-10 English
MRFF Grant Names GTG as Sole Industry Partner 3 pages 147.4KB
Regulatory Filings
2023-09-10 English
2023 Annual Report and Appendix 4E 175 pages 15.0MB
Regulatory Filings
2023-08-30 English
Appendix 4G and Corporate Governance Statement 27 pages 586.5KB
Governance Information
2023-08-30 English
Annual Results Momentum Building on our Commercial Plans 3 pages 117.7KB
Annual Report
2023-08-30 English
Change in substantial holding 5 pages 1.5MB
Major Shareholding Notification
2023-08-16 English
Updated Investor Presentation - August 2023 26 pages 2.6MB
Investor Presentation
2023-08-08 English
Investor Webinar Quarterly Business Update June 2023 1
Investor Presentation
2023-08-02 English
Appendix 4C and Quarterly Activities Report - June 2023 8 pages 529.1KB
Interim / Quarterly Report
2023-07-27 English
Notification of cessation of securities - GTG 4 pages 23.8KB
Share Issue/Capital Change
2023-07-16 English
Notification of cessation of securities - GTG 4 pages 23.8KB
Regulatory Filings
2023-05-09 English
Updated Investor Presentation and Investor Webinar 25 pages 3.7MB
Investor Presentation
2023-05-01 English
Publication Validates geneType for Melanoma Risk Assessment 2 pages 221.8KB
Regulatory Filings
2023-04-27 English
Appendix 4C & Quarterly Activities Report - March 2023 9 pages 455.3KB
Interim / Quarterly Report
2023-04-26 English
Change in substantial holding 5 pages 312.9KB
Major Shareholding Notification
2023-04-23 English
Publication Validates geneType Prostate Cancer Risk Test 2 pages 185.9KB
Regulatory Filings
2023-04-18 English
GeneType MultiTest Panel Expanded Inclusion of New Diseases 2 pages 216.2KB
Regulatory Filings
2023-03-26 English
Response to ASX Query 5 pages 235.9KB
Regulatory Filings
2023-03-16 English
Further Study Validates geneType Breast Cancer Risk Test 2 pages 212.6KB
Regulatory Filings
2023-03-12 English
Notification of cessation of securities - GTG 4 pages 24.2KB
Regulatory Filings
2023-03-06 English
Change in substantial holding 5 pages 1.6MB
Major Shareholding Notification
2023-02-28 English
Half Year Financial Results Investor Webinar Presentation 24 pages 2.4MB
Interim / Quarterly Report
2023-02-27 English
Appendix 4D & Half-year Financial Report December 2022 22 pages 812.6KB
Interim / Quarterly Report
2023-02-26 English
2023 Half-year Financial Results Investor Webinar 1
Investor Presentation
2023-02-23 English
Receipt of R&D Tax Incentive Refund for geneType Multi Test 1
Regulatory Filings
2023-02-16 English
Notification of cessation of securities - GTG 4 pages 24.2KB
Share Issue/Capital Change
2023-02-16 English
Change in substantial holding 5 pages 1.6MB
Major Shareholding Notification
2023-02-08 English
Business Update - February 2023 27 pages 3.2MB
Investor Presentation
2023-02-08 English
Publication Highlights geneType Outperforms Current Models 3 pages 226.3KB
Regulatory Filings
2023-02-08 English
GTG Announces Closing of US$5M Registered Direct Offering 2 pages 158.3KB
Capital/Financing Update
2023-02-07 English
Prospectus Supplement 56 pages 407.3KB
Capital/Financing Update
2023-02-07 English
Proposed issue of securities - GTG 5 pages 27.8KB
Capital/Financing Update
2023-02-06 English
Application for quotation of securities - GTG 6 pages 27.6KB
Share Issue/Capital Change
2023-02-06 English
Section 708A - Cleansing Notice 1 page 394.6KB
Capital/Financing Update
2023-02-06 English
Genetic Technologies Announces US$5M Registered Direct Offer 2 pages 158.2KB
Capital/Financing Update
2023-02-05 English
Proposed issue of securities - GTG 5 pages 28.4KB
Capital/Financing Update
2023-02-05 English
Supplementary Announcement - Comprehensive Risk Test 3 pages 202.6KB
Regulatory Filings
2023-02-05 English
World First Comprehensive Risk Test-Breast & Ovarian Cancer 3 pages 170.5KB
Regulatory Filings
2023-02-02 English
Appendix 3Y Change of Directors Interest Notice 4 pages 304.0KB
Director's Dealing
2023-02-01 English
GTG to form Strategic Alliance with global leader QIAGEN 3 pages 166.8KB
Capital/Financing Update
2023-01-31 English
Appendix 4C and Quarterly Business Update December 2022 9 pages 329.3KB
Interim / Quarterly Report
2023-01-29 English
Colorectal Cancer Model Presented at ASCOGI Cancer Symposium 2 pages 188.0KB
Investor Presentation
2023-01-23 English
Appendix 3Y - Lindsay Wakefield 4 pages 449.3KB
Director's Dealing
2023-01-10 English
Notification of cessation of securities - GTG 5 pages 26.4KB
Share Issue/Capital Change
2023-01-10 English